Miljöpåverkan
Iptakopan
Miljörisk:
Användning av iptakopan har bedömts medföra försumbar risk för miljöpåverkan.
Nedbrytning:
Iptakopan bryts ned i miljön.
Bioackumulering:
Iptakopan har låg potential att bioackumuleras.
Läs mer
Detaljerad miljöinformation
Environmental Risk Classification
Predicted Environmental Concentration (PEC)
PEC is calculated according to the following formula:
PEC (μg/L) = (A*109*(100-R))/(365*P*V*D*100) = 1.37*10-6 * A * (100 - R) = = 1.37*10-6 * 11.388 kg * 100 = 0.001560 μg/L
Where:
A = 11.388 kg (For the PEC calculation the highest annual amount forecasted to be sold in Sweden in the next 5 years was used)
R = 0 % removal rate
V (L/day) = volume of wastewater per capita and day = 200 (ECHA default) (ECHA 2008)
D = factor for dilution of waste water by surface water flow = 10 (ECHA default) (ECHA 2008)
Predicted No Effect Concentration (PNEC)
Ecotoxicological studies
Algae (Pseudokirchneriella subcapitata) (OECD201) (Study No. 20253147):
NOEC 72 h = 92 mg/L
Crustacean (Daphnia magna, waterflea):
Acute toxicity
EC50 48 h (immobilisation) = > 92.0 mg/L (OECD 202) (Study No. 20253145)
Chronic toxicity
NOEC 21 days (reproduction) = 8.3 mg/L (OECD 211) (Study No. 20210455)
Fish:
Acute toxicity (Cyprinus carpio, carp)
LC50 96 h (lethality) > 92.0 mg/L (OECD 203) (Study No. 20253142)
Chronic toxicity (Pimephales promelas, fathead minnow)
NOEC 32 days (growth) = 0.85 mg/L (OECD 210); no effects on hatching and survival (Study No. 20210454)
Other ecotoxicity data:
Bacterial respiration inhibition
NOEC 3 h = 920 mg/L (activated sludge respiration inhibition) (OECD209) (Study No. 20253149)
Sediment-dwelling organisms (Chironomus riparius, non-biting midge)
NOEC 28 days (emergence and development rate) = 544.64 mg/kg dry sediment (OECD 218) (Study No. 20210456)
PNEC derivation:
PNEC = 85 μg/L (=0.85 mg/L/10=85 μg/L)
PNEC (μg/L) = lowest NOEC/10, where 10 is the assessment factor used if three chronic toxicity studies from three trophic levels are available. The NOEC for the fish species Pimephales promelas, fathead minnow, in a fish early-life stage study has been used for this calculation.
Environmental risk classification (PEC/PNEC ratio)
PEC/PNEC = 0.001560 μg/L / 85 μg/L = 0.0000184, i.e. PEC/PNEC ≤ 0.1 which justifies the phrase "Use of iptacopan has been considered to result in insignificant environmental risk".
Degradation
Biotic degradation
Ready degradability:
4 - 8 % degradation in 28 days, not readily biodegradable (OECD 301B). (Study No. 20253148)
Simulation studies:
DT50 (total system) = 5.7 and 6.8 days (OECD 308) (Study No. 20210453)
The applied radioactivity (AR) steadily decreased from the water phase, with 30.3% and 34.8% AR (mean values), respectively, at the end of the 99-day incubation. This was mostly present as iptacopan transformation products, and iptacopan levels in the water phase at 99 days after treatment (DAT) were only 1.1% and 0.2% AR.
Sediments were exhaustively extracted using THF, ammonium acetate with 5% acetonitrile (pH 5), and acetonitrile. The amount of radioactivity (mean values) extracted from sediment increased to a maximum of 32.4% - 35.1% AR at 7 DAT, and then decreased to 18.3% - 22.3% AR at the end of the incubation. The amount of iptacopan in the sediment extracts decreased to approximately 7% AR at the end of incubation in both test systems. The amount of non-extractable radioactivity increased to a maximum of 40.7 - 46.7% AR by the end of the incubation period (99 DAT). Out of this, an average of 51.5% - 70.6% was associated with the more immobile fractions (humic acids and humin). Mineralisation to 14CO2 reached maximum mean amounts of 4.2% - 4.3% AR and organic volatiles were negligible.
Two major metabolites, M3 and M9, were detected with ≥10% AR in both test systems. They were identified by LC-MS as 4-[4-ethoxy-2-piperidyl) benzoic acid and 4-(4-ethoxy-1-pentadeca-trienoyl-2-piperidyl) benzoic acid. M3 was detected with maximum mean amounts of 19.4% and 20.2% AR on 99 DAT for Calwich Abbey and Golden Lake system, respectively. M9 reached its maximum mean amount after 14 days of incubation with 21.3% - 16.3% AR, mostly in the water phase. Besides M3 and M9, several minor metabolites were detected.
Justification of chosen degradation phrase:
According to the pass criteria for OECD308 studies, iptacopan can be classified as “Iptacopan is degraded in the environment” (DT50 for total system <32 days).
Bioaccumulation
Partitioning coefficient:
log Pow at pH 5 = 0.12
log Pow at pH 7 = 0.3
log Pow at pH 9 = 0.085 (OECD 107) (Study No. 20253141 and 20210451)
Justification of chosen bioaccumulation phrase:
Since log Dow (at pH 7) < 4, iptacopan has low potential for bioaccumulation.
Excretion (metabolism)
In a study in healthy volunteers, following a single 100 mg oral dose of [14C]-iptacopan, mean total excretion of radioactivity (iptacopan and metabolites) was 71.5% in the faeces and 24.8% in the urine. Specifically, 17.9% of the dose was excreted as parent iptacopan in the urine and 16.8% in faeces. The half-life (t½) of iptacopan at steady state is approximately 25 hours after administration of iptacopan 200 mg twice daily (Fabhalta, SUMMARY OF PRODUCT CHARACTERISTICS).
References
-
EMA 2006. Guideline on the environmental risk assessment of medicinal products for human use. EMEA/CHMP/SWP/4447/00 corr 21.
-
ECHA 2008, European Chemicals Agency. 2008 Guidance on information requirements and chemical safety assessment. http://guidance.echa.europa.eu/docs/guidance_document/information_requirements_en.htm
-
Fabhalta, SUMMARY OF PRODUCT CHARACTERISTICS, accessed on 18th December 2024, available from: https://ec.europa.eu/health/documents/community-register/2024/20240517162437/anx_162437_en.pdf.
-
Study No. 20253145
-
Study No. 20253148
-
Study No. 20210453
-
Study No. 20253141
-
Study No. 20210451
-
Study No. 20253147
-
Study No. 20210455
-
Study No. 20210454
-
Study No. 20253149
-
Study No. 20253142
-
Study No. 20210456